Department of Plastic and Reconstructive Surgery, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Tissue Engineering, Shanghai, PR China; National Tissue Engineering Center of China, Shanghai, PR China.
Department of Plastic and Reconstructive Surgery, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Tissue Engineering, Shanghai, PR China.
Biomaterials. 2014 Jun;35(18):4878-87. doi: 10.1016/j.biomaterials.2014.02.043. Epub 2014 Mar 19.
Previously, we had addressed the issues of shape control/maintenance of in vitro engineered human-ear-shaped cartilage. Thus, lack of applicable cell source had become a major concern that blocks clinical translation of this technology. Autologous microtia chondrocytes (MCs) and bone marrow stromal cells (BMSCs) were both promising chondrogenic cells that did not involve obvious donor site morbidity. However, limited cell availability of MCs and ectopic ossification of chondrogenically induced BMSCs in subcutaneous environment greatly restricted their applications in external ear reconstruction. The current study demonstrated that MCs possessed strong proliferation ability but accompanied with rapid loss of chondrogenic ability during passage, indicating a poor feasibility to engineer the entire ear using expanded MCs. Fortunately, the co-transplantation results of MCs and BMSCs (25% MCs and 75% BMSCs) demonstrated a strong chondroinductive ability of MCs to promote stable ectopic chondrogenesis of BMSCs in subcutaneous environment. Moreover, cell labeling demonstrated that BMSCs could transform into chondrocyte-like cells under the chondrogenic niche provided by co-cultured MCs. Most importantly, a human-ear-shaped cartilaginous tissue with delicate structure and proper elasticity was successfully constructed by seeding the mixed cells (MCs and BMSCs) into the pre-shaped biodegradable ear-scaffold followed by 12 weeks of subcutaneous implantation in nude mouse. These results may provide a promising strategy to construct stable ectopic cartilage with MCs and stem cells (BMSCs) for autologous external ear reconstruction.
此前,我们已经解决了体外工程人耳状软骨的形状控制/维持问题。因此,缺乏适用的细胞来源成为阻碍该技术临床转化的主要问题。自体小耳软骨细胞(MCs)和骨髓基质细胞(BMSCs)都是有前途的软骨细胞,它们不会引起明显的供体部位发病率。然而,MCs 的细胞可用性有限,以及软骨诱导的 BMSCs 在皮下环境中的异位成骨,极大地限制了它们在外耳重建中的应用。本研究表明,MCs 具有很强的增殖能力,但在传代过程中伴随着软骨生成能力的迅速丧失,表明使用扩增的 MCs 来构建整个耳朵的可行性较差。幸运的是,MCs 和 BMSCs 的共移植结果(25%MCs 和 75%BMSCs)显示 MCs 具有很强的软骨诱导能力,可以促进 BMSCs 在皮下环境中的稳定异位软骨生成。此外,细胞标记表明,BMSCs 在共培养的 MCs 提供的软骨生成龛位下可以转化为软骨细胞样细胞。最重要的是,通过将混合细胞(MCs 和 BMSCs)接种到预先成型的可生物降解的耳朵支架中,然后在裸鼠皮下植入 12 周,成功构建了具有精细结构和适当弹性的人耳状软骨组织。这些结果可能为使用 MCs 和干细胞(BMSCs)构建稳定的异位软骨提供了一种有前途的策略,用于自体外耳重建。